Harvard Bioscience (HBIO) Change in Inventory (2010 - 2026)

Harvard Bioscience (HBIO) has 17 years of Change in Inventory data on file, last reported at $1.5 million in Q1 2026.

• On a quarterly basis, Change in Inventory rose 329.85% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was -$737000.0, a 39.74% increase from a year earlier, with the FY2025 full-year figure at -$2.9 million, down 4704.69% from the prior year.
• Change in Inventory for Q1 2026 stood at $1.5 million, up from -$663000.0 in the prior quarter.
• Over the last five years, Change in Inventory for HBIO reached as high as $1.5 million in Q1 2026 and fell as low as -$2.4 million in Q4 2024.
• Historically, Change in Inventory has averaged -$183470.6 across 5 years, with a median of -$581000.0 in 2022.
• Across the five-year window, Change in Inventory tumbled 253.61% in 2022 and jumped 329.85% in 2026, its largest moves.
• Year by year, Change in Inventory stood at -$581000.0 in 2022, then tumbled by 132.53% to -$1.4 million in 2023, then tumbled by 74.09% to -$2.4 million in 2024, then soared by 71.81% to -$663000.0 in 2025, then surged by 332.28% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were $1.5 million in Q1 2026, -$663000.0 in Q4 2025, and -$637000.0 in Q3 2025.